Dokumentenart: | Artikel | ||||
---|---|---|---|---|---|
Höhe Gebühr (aus OpenAPC): | 2345.06 | ||||
Institution der Zahlung: | Heidelberg U | ||||
Titel eines Journals oder einer Zeitschrift: | Journal of Neuroinflammation | ||||
Verlag: | BMC | ||||
Ort der Veröffentlichung: | LONDON | ||||
Band: | 19 | ||||
Nummer des Zeitschriftenheftes oder des Kapitels: | 1 | ||||
Datum: | 2022 | ||||
Institutionen: | Medizin > Lehrstuhl für Neurologie | ||||
Identifikationsnummer: |
| ||||
Stichwörter / Keywords: | SIMPLEX-VIRUS ENCEPHALITIS; BLOOD-CSF BARRIER; ALPHA TNF-ALPHA; MULTIPLE-SCLEROSIS; NEUROLOGICAL MANIFESTATIONS; OLIGOCLONAL IGG; INTRATHECAL SYNTHESIS; NEUROMYELITIS-OPTICA; QUALITATIVE EVIDENCE; CHOROID-PLEXUS; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2); Neurological symptoms; Lumbar puncture; Cerebrospinal fluid (CSF); Oligoclonal bands; Blood-CSF barrier; Polymerase Chain reaction (PCR); SARS-CoV-2 antibodies; Antibody index; Autoantibodies; Cytokines; Central nervous system; Encephalopathy; Encephalitis; Guillain-Barre syndrome | ||||
Dewey-Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||
Status: | Veröffentlicht | ||||
Begutachtet: | Ja, diese Version wurde begutachtet | ||||
An der Universität Regensburg entstanden: | Ja | ||||
Dokumenten-ID: | 57771 |
Zusammenfassung
Background Comprehensive data on the cerebrospinal fluid (CSF) profile in patients with COVID-19 and neurological involvement from large-scale multicenter studies are missing so far. Objective To analyze systematically the CSF profile in COVID-19. Methods Retrospective analysis of 150 lumbar punctures in 127 patients with PCR-proven COVID-19 and neurological symptoms seen at 17 European ...
Zusammenfassung
Background Comprehensive data on the cerebrospinal fluid (CSF) profile in patients with COVID-19 and neurological involvement from large-scale multicenter studies are missing so far. Objective To analyze systematically the CSF profile in COVID-19. Methods Retrospective analysis of 150 lumbar punctures in 127 patients with PCR-proven COVID-19 and neurological symptoms seen at 17 European university centers Results The most frequent pathological finding was blood-CSF barrier (BCB) dysfunction (median QAlb 11.4 [6.72-50.8]), which was present in 58/116 (50%) samples from patients without pre-/coexisting CNS diseases (group I). QAlb remained elevated > 14d (47.6%) and even > 30d (55.6%) after neurological onset. CSF total protein was elevated in 54/118 (45.8%) samples (median 65.35 mg/dl [45.3-240.4]) and strongly correlated with QAlb. The CSF white cell count (WCC) was increased in 14/128 (11%) samples (mostly lympho-monocytic; median 10 cells/mu l, > 100 in only 4). An albuminocytological dissociation (ACD) was found in 43/115 (37.4%) samples. CSF l-lactate was increased in 26/109 (24%; median 3.04 mmol/l [2.2-4]). CSF-IgG was elevated in 50/100 (50%), but was of peripheral origin, since QIgG was normal in almost all cases, as were QIgA and QIgM. In 58/103 samples (56%) pattern 4 oligoclonal bands (OCB) compatible with systemic inflammation were present, while CSF-restricted OCB were found in only 2/103 (1.9%). SARS-CoV-2-CSF-PCR was negative in 76/76 samples. Routine CSF findings were normal in 35%. Cytokine levels were frequently elevated in the CSF (often associated with BCB dysfunction) and serum, partly remaining positive at high levels for weeks/months (939 tests). Of note, a positive SARS-CoV-2-IgG-antibody index (AI) was found in 2/19 (10.5%) patients which was associated with unusually high WCC in both of them and a strongly increased interleukin-6 (IL-6) index in one (not tested in the other). Anti-neuronal/anti-glial autoantibodies were mostly absent in the CSF and serum (1509 tests). In samples from patients with pre-/coexisting CNS disorders (group II [N = 19]; including multiple sclerosis, JC-virus-associated immune reconstitution inflammatory syndrome, HSV/VZV encephalitis/meningitis, CNS lymphoma, anti-Yo syndrome, subarachnoid hemorrhage), CSF findings were mostly representative of the respective disease. Conclusions The CSF profile in COVID-19 with neurological symptoms is mainly characterized by BCB disruption in the absence of intrathecal inflammation, compatible with cerebrospinal endotheliopathy. Persistent BCB dysfunction and elevated cytokine levels may contribute to both acute symptoms and 'long COVID'. Direct infection of the CNS with SARS-CoV-2, if occurring at all, seems to be rare. Broad differential diagnostic considerations are recommended to avoid misinterpretation of treatable coexisting neurological disorders as complications of COVID-19.
Metadaten zuletzt geändert: 29 Feb 2024 13:02